REPL·76029N106·US·Common Stock·Healthcare - Biotechnology-Activist
REPL (REPLIMUNE GROUP INC) is held by 105 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($84.5M), RTW INVESTMENTS, LP ($56.3M), BlackRock, Inc. ($47.7M). Net institutional sentiment: Mixed.
Showing 1-20 of 115
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer